Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pharmaniaga BhdXKLS:7081 45 Days Payable is 76.77 as of Mar. 2026, which is 0% above its 10-year median of 76.69. GuruFocus rates XKLS:7081 with a GF Score™ of 45/100 and a GF Value™ of RM0.71 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 116 Medical Distribution companies, Pharmaniaga Bhd ranks better than 58.62% on this metric.
The historical rank and industry rank for Pharmaniaga Bhd's Days Payable or its related term are showing as below:
XKLS:7081'
s Days Payable Range Over the Past 10 Years
Min: 51.18 Med: 76.69 Max: 94.81
Current: 91.11
During the past 13 years, Pharmaniaga Bhd's highest Days Payable was 94.81. The lowest was 51.18. And the median was 76.69.
XKLS:7081's Days Payable is ranked better than 58.62% of 116
companies
in the Medical Distribution industry
Industry Median: 79.46
vs XKLS:7081: 91.11
Pharmaniaga Bhd's Days Payable
declined
from Mar. 2025 (80.94) to Mar. 2026 (76.77).
It may suggest that Pharmaniaga Bhdaccelerated paying its suppliers.
Pharmaniaga Bhd Days Payable Related Terms
Pharmaniaga Bhd Days Payable Historical Data
* Premium members only.
The historical data trend for Pharmaniaga Bhd's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:7081 vs MCK, CAH, COR: Days Payable Comparison
For the Medical Distribution subindustry, Pharmaniaga Bhd's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharmaniaga Bhd Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Pharmaniaga Bhd's Days Payable distribution charts can be found below:
* The bar in red indicates where Pharmaniaga Bhd's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Pharmaniaga Bhd's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmaniaga Bhd (XKLS:7081) has a Days Payable of 76.77 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Pharmaniaga Bhd and its competitors. This is near median its historical median of 76.69. Over the past decade, Pharmaniaga Bhd's Days Payable has ranged from 51.18 to 94.81. According to the industry distribution chart, Pharmaniaga Bhd ranks #48 out of 116 companies in the Medical Distribution industry, placing it in the top 41.4%.
Is Pharmaniaga Bhd's Days Payable too high?
Pharmaniaga Bhd's current Days Payable of 76.77 is near median its 10-year median of 76.69. Over the past 10 years, this metric has ranged from a low of 51.18 to a high of 94.81. The Medical Distribution industry median Days Payable is 79.46. Pharmaniaga Bhd's value of 76.77 is 3.4% below this industry median. Based on the distribution chart, Pharmaniaga Bhd ranks #48 out of 116 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Pharmaniaga Bhd has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pharmaniaga Bhd's Days Payable compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Pharmaniaga Bhd ranks #48 out of 116 companies for Days Payable. This puts Pharmaniaga Bhd in the upper half of its industry. The industry median Days Payable is 79.46. Pharmaniaga Bhd's value of 76.77 is 3.4% below this benchmark. Historically, Pharmaniaga Bhd's own Days Payable has ranged from 51.18 to 94.81 over the past decade. While the company's 10-year median is 76.69 vs. the industry median of 79.46, Pharmaniaga Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 79.46, based on 116 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pharmaniaga Bhd's current Days Payable of 76.77 is 3.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Pharmaniaga Bhd and its competitors. For the Medical Distribution industry, the median Days Payable is 79.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharmaniaga Bhd's current Days Payable is 76.77, which is near median its own 10-year median of 76.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmaniaga Bhd stock overvalued right now?
Based on GuruFocus' analysis, Pharmaniaga Bhd (XKLS:7081) is currently considered Significantly Overvalued. The stock's GF Value™ is RM0.71, compared to a current price of RM1.17 — trading 64.8% above its estimated fair value. The current Days Payable is 76.77, which is near median its 10-year median of 76.69 and 3.4% below the Medical Distribution industry median of 79.46. Pharmaniaga Bhd's overall GF Score™ is 45/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Pharmaniaga Bhd (XKLS:7081), the current Days Payable is 76.77 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pharmaniaga Bhd (XKLS:7081) Overvalued in 2026?
Based on GuruFocus' analysis, Pharmaniaga Bhd stock appears to be overvalued.
The current stock price of RM1.17 is trading 64.8% above its estimated GF Value™ of RM0.71.
GuruFocus considers Pharmaniaga Bhd to be Significantly Overvalued.
Key valuation signals for XKLS:7081:
Days Payable: 76.77 (near median its 10-year median of 76.69)
GF Value™: RM0.71 vs. price of RM1.17 (64.8% above fair value)
Industry Position: 3.4% below the Medical Distribution median (#48 of 116)
No single metric tells the full story. See the XKLS:7081 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pharmaniaga Bhd is engaged in the manufacture of pharmaceuticals and medical devices. The company is also involved in logistics and distribution. The group operates in three segments - Logistics and distribution, Manufacturing in Malaysia, and Manufacturing and distribution in Indonesia. Maximum revenue is generated by the logistics and distribution segment in Malaysia. The Logistics and distribution segment is engaged in distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia.
45GF Score
Get the complete analysis for XKLS:7081
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7081 has been successfully added to your 
